• 1
    Cerrato F, Sparago A, Verde G et al. Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour. Hum Mol Genet 2008; 17: 14271435.
  • 2
    Adewumi O, Aflatoonian B, Ahrlund-Richter L et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007; 25: 803816.
  • 3
    Rugg-Gunn PJ, Ferguson-Smith AC, Pedersen RA. Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. Hum Mol Genet 2007; 16: R243R251.
  • 4
    Rugg-Gunn PJ, Ferguson-Smith AC, Pedersen RA. Epigenetic status of human embryonic stem cells. Nat Genet 2005; 37: 585587.
  • 5
    Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861872.
  • 6
    Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 19171920.
  • 7
    Wernig M, Meissner A, Foreman R et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; 448: 318324.
  • 8
    Daley GQ, Lensch MW, Jaenisch R et al. Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell 2009; 4: 200-201.
  • 9
    Humpherys D, Eggan K, Akutsu H et al. Epigenetic instability in ES cells and cloned mice. Science 2001; 293: 9597.
  • 10
    Maherali N, Ahfeldt T, Rigamonti A et al. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 2008; 3: 340345.
  • 11
    Masaki H, Ishikawa T, Takahashi S et al. Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culture. Stem Cell Res 2007; 1: 105115.
  • 12
    Park IH, Zhao R, West JA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451: 141146.
  • 13
    Lowry WE, Richter L, Yachechko R et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A 2008; 105: 28832888.
  • 14
    Ebert AD, Yu J, Rose FF Jr et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457: 277280.
  • 15
    Yu J, Hu K, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797801.
  • 16
    Feng W, Marquez RT, Lu Z et al. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 2008; 112: 14891502.
  • 17
    Pedersen IS, Dervan PA, Broderick D et al. Frequent loss of imprinting of PEG1/MEST in invasive breast cancer. Cancer Res 1999; 59: 54495451.
  • 18
    Fukuzawa R, Heathcott RW, Morison IM et al. Imprinting, expression, and localisation of DLK1 in Wilms tumours. J Clin Pathol 2005; 58: 145150.
  • 19
    Astuti D, Latif F, Wagner K et al. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: Analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer 2005; 92: 15741580.